SIGNAL TRANSDUCTION IN CELL PROLIFERATION
SIGNAL TRANSDUCTION IN CELL PROLIFERATION
批准号:
2189551
负责人:
David Randell Manning
金额:
$19.72万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-04-01 至 1998-11-30
关键词:
3T3 cells DNA replication G protein SDS polyacrylamide gel electrophoresis biological signal transduction bombesin cell cycle gastrins gene mutation growth factor laboratory rabbit mitogens phosphorylation polymerase chain reaction posttranslational modifications receptor expression thrombin tissue /cell culture transfection western blottings
中文摘要
本提案的目的是确定和表征GTP结合
与细胞增殖相关的调节蛋白(G蛋白)。G
蛋白质通常在信号转导中起着强制性的作用,
信息从细胞表面受体传递到靶细胞
酶或通道。几种生长因子利用G蛋白,
这是它们发挥促有丝分裂作用的唯一手段,而其他
通过联合使用G蛋白依赖性和-
独立的道路。虽然G蛋白在免疫系统中起着重要作用,
扩散,那些真正与之交流的人的身份
生长因子受体或作为下游靶点的受体
修改不清楚。此外,这些G蛋白的功能是
不太了解。提出了四个实验目标。首先,G蛋白
直接与之相互作用,或者以某种方式被其激活,
将鉴定生长因子的受体。 战略包括:
受体免疫沉淀,G蛋白复合物,光亲和性
用[32 P] γ-叠氮苯胺基GTP标记,并测量生长
GDP/GTP比率的变化。本目标和后续目标的重点将
被放置在与凝血酶和蛙皮素/胃泌素相关的G蛋白上-
释放肽(GRP),两种广泛公认的有丝分裂原,
通过七螺旋受体和G蛋白。 第二,子集
G蛋白的活化或修饰是特别需要的
细胞复制的能力。实验重点将是
凝血酶和GRP在静止细胞中重新启动DNA合成,
单层培养策略包括显微注射抗体,
破坏G蛋白与受体或靶标的通讯,
G蛋白的百日咳毒素抗性类似物,和显性阴性
调变第三,生长因子利用的G蛋白阵列将
相对于其他激动剂使用的药物进行检查,
寻找与有丝分裂相关的G蛋白。问题
包括什么-如所定义的G蛋白的水平利用,
随后的下游事件-将激动剂鉴定为促有丝分裂的,和
G蛋白通过什么样的分子事件来激活
MAP激酶。第四,G蛋白在多大程度上受到后
转化后的翻译修饰
将检查DNA合成的重新启动。最近两次修改
证明了G蛋白α亚基,酪氨酸磷酸化和
棕榈酰化,将构成重点。对G蛋白的理解
在生长因子作用的背景下,
与细胞相关的通路的身份和协调
复制的
英文摘要
The objective of this proposal is to identify and characterize GTP-binding
regulatory proteins (G proteins) relevant to cell proliferation. G
proteins serve often obligatory roles in signal transduction, the process
by which information is conveyed from cell-surface receptors to target
enzymes or channels. Several growth factors utilize G proteins as perhaps
the sole means by which their mitogenic actions are exerted, while others
act in synergy through conjoint use of both G protein-dependent and -
independent pathways. Although G proteins serve fundamental roles in
proliferation, the identities of those actually communicating with
receptors for growth factors or those serving as targets for downstream
modification are unclear. The functions of such G proteins, moreover, are
poorly understood. Four experimental goals are proposed. First, G proteins
that interact directly with, or in some fashion are activated by,
receptors for growth factors will be identified. Strategies include co-
immunoprecipitation of receptor.G protein complexes, photoaffinity
labeling with [32P]gamma-azidoanilido GTP, and measurements of growth
factor-altered GDP/GTP ratios. The focus in this and subsequent goals will
be placed on G proteins relevant to thrombin and bombesin/gastrin-
releasing peptide (GRP), two widely recognized mitogens that operate
through heptahelical receptors and hence G proteins. Second, the subset
of G proteins whose activation or modification is specifically required
for cell replication will be identified. The experimental focus will be
reinitiation of DNA synthesis by thrombin and GRP in quiescent cells in
monolayer culture. Strategies include microinjection of antibodies that
disrupt communication of G proteins with receptors or targets, the use of
pertussis toxin-resistant analogues of G proteins, and dominant negative
modulation. Third, the array of G proteins utilized by growth factors will
be examined relative to those used by other agonists, and specific roles
for the G proteins relevant to mitogenesis will be sought. Questions
include what - as defined at the level of G proteins utilized and
subsequent downstream events - identifies an agonist as mitogenic, and
what are the molecular events by which G proteins achieve activation of
MAP kinases. Fourth, the extent to which G proteins are subject to post-
translational modification upon transformation and in relation to
reinitiation of DNA synthesis will be examined. Two modifications recently
demonstrated for G protein alpha subunits, tyrosine phosphorylation and
palmitoylation, will constitute the focus. An understanding of G proteins
in the context of growth factor action will provide substantial insight
into the identities and coordination of pathways relevant to cell
replication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engagement of heterotrimeric G proteins by Sonic hedgehog
-
批准号:7874858
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2009
-
负责人:David Randell Manning
-
依托单位:
Engagement of heterotrimeric G proteins by Sonic hedgehog
-
批准号:8630676
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2007
-
负责人:David Randell Manning
-
依托单位:
Engagement of heterotrimeric G proteins by Sonic hedgehog
-
批准号:7905188
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2007
-
负责人:David Randell Manning
-
依托单位:
Engagement of heterotrimeric G proteins by Sonic hedgehog
-
批准号:7499716
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:David Randell Manning
-
依托单位:
Engagement of heterotrimeric G proteins by Sonic hedgehog
-
批准号:7371484
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:David Randell Manning
-
依托单位:
Engagement of heterotrimeric G proteins by Sonic hedgehog
-
批准号:7678435
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:David Randell Manning
-
依托单位:
Engagement of heterotrimeric G proteins by Sonic hedgehog
-
批准号:8788534
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2007
-
负责人:David Randell Manning
-
依托单位:
RECEPTOR COUPLING TO G12 AND G13
-
批准号:7087747
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2003
-
负责人:David Randell Manning
-
依托单位:
RECEPTOR COUPLING TO G12 AND G13
-
批准号:6765321
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2003
-
负责人:David Randell Manning
-
依托单位:
RECEPTOR COUPLING TO G12 AND G13
-
批准号:6910709
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2003
-
负责人:David Randell Manning
-
依托单位:
RECEPTOR COUPLING TO G12 AND G13
-
批准号:6688132
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2003
-
负责人:David Randell Manning
-
依托单位:
SF9 CELL STUDY OF 5 HT1A RECEPTOR G PROTEIN COUPLING
-
批准号:6353118
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2000
-
负责人:David Randell Manning
-
依托单位:
SF9 CELL STUDY OF 5 HT1A RECEPTOR G PROTEIN COUPLING
-
批准号:6204856
-
项目类别:
-
资助金额:$17.61万
-
财政年份:1999
-
负责人:David Randell Manning
-
依托单位:
SF9 CELL STUDY OF 5 HT1A RECEPTOR G PROTEIN COUPLING
-
批准号:6111553
-
项目类别:
-
资助金额:$17.61万
-
财政年份:1998
-
负责人:David Randell Manning
-
依托单位:
SF9 CELL STUDY OF 5 HT1A RECEPTOR G PROTEIN COUPLING
-
批准号:6243163
-
项目类别:
-
资助金额:$16.91万
-
财政年份:1997
-
负责人:David Randell Manning
-
依托单位:
LIPID MODIFICATION OF G PROTEIN ALPHA SUBUNITS
-
批准号:2192443
-
项目类别:
-
资助金额:$16.84万
-
财政年份:1995
-
负责人:David Randell Manning
-
依托单位:
LIPID MODIFICATION OF G PROTEIN ALPHA SUBUNITS
-
批准号:2444873
-
项目类别:
-
资助金额:$15.82万
-
财政年份:1995
-
负责人:David Randell Manning
-
依托单位:
LIPID MODIFICATION OF G PROTEIN ALPHA SUBUNITS
-
批准号:2192444
-
项目类别:
-
资助金额:$15.21万
-
财政年份:1995
-
负责人:David Randell Manning
-
依托单位:
LIPID MODIFICATION OF G PROTEIN ALPHA SUBUNITS
-
批准号:2734774
-
项目类别:
-
资助金额:$16.46万
-
财政年份:1995
-
负责人:David Randell Manning
-
依托单位:
BIOCHEMICAL PROPERTIES OF SOMATOSTATIN RECEPTORS
-
批准号:2246649
-
项目类别:
-
资助金额:$19.28万
-
财政年份:1989
-
负责人:David Randell Manning
-
依托单位:
海外基金